Abstract
O-278: Economic impact of the FSH choice (urinary or recombinant) on ART cost. Data from a new randomized controlled trial
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
